- Report
- September 2023
- 87 Pages
Africa, Middle East
From €2700EUR$2,950USD£2,295GBP
- Report
- September 2023
- 107 Pages
Asia Pacific
From €3158EUR$3,450USD£2,684GBP
- Report
- September 2023
- 101 Pages
North America
From €2700EUR$2,950USD£2,295GBP
- Report
- September 2023
- 194 Pages
Global
From €4531EUR$4,950USD£3,851GBP
- Report
- June 2022
- 215 Pages
United States
From €2471EUR$2,699USD£2,100GBP
- Report
- February 2021
- 80 Pages
India
From €1089EUR$1,190USD£926GBP
- Report
- January 2021
- 109 Pages
Global
€3990EUR$4,669USD£3,510GBP
- Report
- August 2019
- 76 Pages
Global
€2746EUR$3,000USD£2,334GBP
- Report
- July 2018
- 224 Pages
Global
From €1648EUR$1,800USD£1,400GBP
- Report
- March 2025
- 92 Pages
Global
From €3500EUR$4,096USD£3,079GBP
- Report
- November 2024
- 78 Pages
Global
From €3500EUR$4,096USD£3,079GBP
- Report
- November 2024
- 86 Pages
Global
From €3500EUR$4,096USD£3,079GBP
- Report
- December 2024
- 339 Pages
Global
From €1701EUR$1,859USD£1,446GBP
€2430EUR$2,655USD£2,066GBP
- Report
- November 2024
- 130 Pages
Asia Pacific
From €1191EUR$1,301USD£1,012GBP
€1702EUR$1,859USD£1,446GBP
- Report
- August 2024
- 300 Pages
Global
From €1701EUR$1,859USD£1,446GBP
€2430EUR$2,655USD£2,066GBP
- Report
- April 2024
- 350 Pages
Global
From €2461EUR$2,688USD£2,091GBP
€3515EUR$3,840USD£2,987GBP
- Report
- October 2022
- 258 Pages
Global
From €2288EUR$2,499USD£1,944GBP
€3268EUR$3,570USD£2,777GBP
- Book
- February 2025
- 432 Pages
- Book
- March 2024
- 528 Pages

The Vaccine Development market is a subset of the Vaccines industry, which focuses on the research, development, and production of vaccines. Vaccines are biological preparations that provide active acquired immunity to a particular disease. Vaccine development involves the identification of antigens, the development of a vaccine formulation, and the production of the vaccine. Vaccine development is a complex process that requires significant resources and expertise.
The Vaccine Development market is highly competitive, with many companies competing to develop and produce vaccines. Companies in the market include Merck & Co., GlaxoSmithKline, Sanofi, Pfizer, Johnson & Johnson, and Novavax. Show Less Read more